[ad_1]
The phase 3 study of the Covid-19 vaccine, developed by AstraZeneca and the University of Oxford, was discontinued after a participant in the UK experienced suspected serious side effects. In the statement made by AstraZeneca, it was announced that global trials of the coronavirus vaccine were on hold due to an unexplained illness in one of the volunteers.
In the statement, it was noted that experimental vaccines were a standard measure in vaccine trials to prevent serious side effects among participants.
According to the CNN International news story, as part of the ongoing global controlled trials of the Oxford coronavirus vaccine, the standard review process stopped vaccination studies to review safety data.
“This is a routine action that should occur during research, and that allows us to maintain the integrity of the trials, when there is potentially unexplained illness in one of the trials. In large trials, illnesses occur by chance, but this it should be independently reviewed to monitor carefully. To maximize any possible effects, “the statement said. “We are working to minimize. We are committed to the safety of our participants.”
DECISION TO ‘CONTINUE STUDIES’
According to the news in the Financial Times newspaper; AstraZeneca, which has developed a coronavirus vaccine with the University of Oxford, will be able to continue its suspended clinical trials next week.
